Taken together, the results above suggested that the synergistic effect of IM and OAG against CML cells in vivo could be attributed to suppressing Hh pathway and BCR-ABL expression. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.